1. Home
  2. MIST vs CULP Comparison

MIST vs CULP Comparison

Compare MIST & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • CULP
  • Stock Information
  • Founded
  • MIST 2003
  • CULP 1972
  • Country
  • MIST Canada
  • CULP United States
  • Employees
  • MIST N/A
  • CULP N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • CULP Textiles
  • Sector
  • MIST Health Care
  • CULP Consumer Discretionary
  • Exchange
  • MIST Nasdaq
  • CULP Nasdaq
  • Market Cap
  • MIST 53.9M
  • CULP 47.5M
  • IPO Year
  • MIST N/A
  • CULP N/A
  • Fundamental
  • Price
  • MIST $1.11
  • CULP $4.02
  • Analyst Decision
  • MIST Strong Buy
  • CULP
  • Analyst Count
  • MIST 2
  • CULP 0
  • Target Price
  • MIST $9.50
  • CULP N/A
  • AVG Volume (30 Days)
  • MIST 1.6M
  • CULP 15.1K
  • Earning Date
  • MIST 05-20-2025
  • CULP 06-26-2025
  • Dividend Yield
  • MIST N/A
  • CULP N/A
  • EPS Growth
  • MIST N/A
  • CULP N/A
  • EPS
  • MIST N/A
  • CULP N/A
  • Revenue
  • MIST N/A
  • CULP $213,993,000.00
  • Revenue This Year
  • MIST N/A
  • CULP N/A
  • Revenue Next Year
  • MIST N/A
  • CULP $5.99
  • P/E Ratio
  • MIST N/A
  • CULP N/A
  • Revenue Growth
  • MIST N/A
  • CULP N/A
  • 52 Week Low
  • MIST $0.63
  • CULP $3.42
  • 52 Week High
  • MIST $2.75
  • CULP $6.85
  • Technical
  • Relative Strength Index (RSI)
  • MIST 43.96
  • CULP 47.97
  • Support Level
  • MIST $1.28
  • CULP $3.89
  • Resistance Level
  • MIST $1.32
  • CULP $4.10
  • Average True Range (ATR)
  • MIST 0.12
  • CULP 0.23
  • MACD
  • MIST 0.02
  • CULP 0.08
  • Stochastic Oscillator
  • MIST 27.39
  • CULP 85.71

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About CULP Culp Inc.

Culp Inc manufactures, sources, and markets mattress fabrics and sewn covers used for covering mattresses and box springs and upholstery fabrics including cut and sewn kits used in the production of upholstered furniture. The company has two operating segments Mattress fabrics which generates maximum revenue, and Upholstery fabrics. The mattress fabrics segment, also known as Culp Home Fashions, manufactures and markets mattress fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment markets fabrics for residential, commercial, and hospitality furniture and also provides window treatment products and installation services for its customers in the hospitality and commercial industries. Geographically, it derives key revenue from the United States of America.

Share on Social Networks: